Theseus Pharmaceuticals, Inc. THRX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

Theseus Pharmaceuticals, Inc. (THRX) — Analyst outlook / Analyst consensus target is. Based on 12 analyst ratings, the consensus is bullish — 8 Buy, 4 Hold.

THRX Analyst Ratings

Buy

Ratings

8 Buy

4 Hold

Based on 12 analysts giving stock ratings to Theseus Pharmaceuticals, Inc. in the past 3 months

Rating breakdown

Buy

8 67%

Hold

4 33%

67%

Buy

8 analysts

33%

Hold

4 analysts

Sell

0 analysts

People Also View

BPMC

Blueprint Medicines Corporation

Terns Pharmaceuticals, Inc.

$52.68

+0.13%

ELVN

Enliven Therapeutics, Inc.

$44.85

+2.33%

RLAY

Relay Therapeutics, Inc.

$14.75

-3.34%

RCUS

Arcus Biosciences, Inc.

$23.01

+2.77%

DAWN

Day One Biopharmaceuticals, Inc.

$21.46

-0.14%

GLUE

Monte Rosa Therapeutics, Inc.

$17.50

-0.28%

Theseus Pharmaceuticals, Inc. THRX NASDAQ

THRX Analyst Ratings

People Also View

Get Undervalued Stock Alerts